Abstract
Motivation: Despite its great success in various physical modeling, differential geometry (DG) has rarely been devised as a versatile tool for analyzing large, diverse, and complex molecular and biomolecular datasets because of the limited understanding of its potential power in dimensionality reduction and its ability to encode essential chemical and biological information in differentiable manifolds. Results: We put forward a differential geometry-based geometric learning (DG-GL) hypothesis that the intrinsic physics of three-dimensional (3D) molecular structures lies on a family of low-dimensional manifolds embedded in a high-dimensional data space. We encode crucial chemical, physical, and biological information into 2D element interactive manifolds, extracted from a high-dimensional structural data space via a multiscale discrete-to-continuum mapping using differentiable density estimators. Differential geometry apparatuses are utilized to construct element interactive curvatures in analytical forms for certain analytically differentiable density estimators. These low-dimensional differential geometry representations are paired with a robust machine learning algorithm to showcase their descriptive and predictive powers for large, diverse, and complex molecular and biomolecular datasets. Extensive numerical experiments are carried out to demonstrate that the proposed DG-GL strategy outperforms other advanced methods in the predictions of drug discovery-related protein-ligand binding affinity, drug toxicity, and molecular solvation free energy.
Duc Nguyen
Associate Professor of Mathematics
Duc Nguyen develops mathematical and AI frameworks for molecular bioscience, drug discovery, and scientific computing. His group blends differential geometry, graph theory, and machine learning to build high-fidelity models for biomolecular systems, with notable wins in the D3R Grand Challenges and collaborations with Pfizer and Bristol Myers Squibb. Supported by multiple NSF awards, he has advised students and postdocs across theory and applications of AI-driven drug design.